The NUTRI-ENDO Clinical Protocol: Standardized PreTreatment Nutraceutical Optimization with Evidence-Based Vitamin-Mineral Matrix for Endometriosis Management

Viktoriya Hudziak
2026 · doi:10.5281/zenodo.22129193 · W7204448718
OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-31 ⓘ

The NUTRI-ENDO protocol establishes a standardized, evidence-based vitamin-mineral matrix to optimize the metabolic and immunological milieu in endometriosis patients prior to definitive therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-31 · read from full text ⓘ

This paper presents the NUTRI-ENDO clinical protocol, a standardized framework for optimizing pre-treatment nutritional status in patients with endometriosis. The authors developed this evidence-based vitamin-mineral matrix by systematically reviewing randomized controlled trials and mechanistic studies from 2010 to 2026 regarding inflammation and estrogen metabolism. The resulting protocol specifies twelve core nutraceuticals, including Vitamin D3, omega-3 fatty acids, and curcumin, with defined dosing and monitoring parameters across baseline, priming, and peri-operative phases. This paper is centrally about endometriosis — specifically, it provides a detailed clinical protocol for pre-treatment nutraceutical optimization to manage the condition's associated inflammation and oxidative stress.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis affects approximately 10% of reproductive-age women and is frequently associated with chronic inflammation, oxidative stress, estrogen dominance, and micronutrient deficiencies. Despite advances in surgical and hormonal therapy, pre-treatment optimization of the metabolic and immunological milieu remains understandardized. Nutraceutical intervention represents a low-risk, evidence-informed adjunct capable of modulating key pathophysiological pathways prior to definitive therapy. Objective: To present a standardized, reproducible clinical protocol — NUTRI-ENDO — for pretreatment nutraceutical optimization in endometriosis patients utilizing a structured vitamin-mineral matrix. Methods: The protocol was developed through systematic review of randomized controlled trials, metaanalyses, and mechanistic studies (2010–2026) concerning nutraceutical modulation of endometriosisassociated inflammation, angiogenesis, apoptosis dysregulation, and estrogen metabolism. A multidisciplinary panel synthesized evidence into a tiered implementation framework with defined dosing, timing, monitoring parameters, and safety algorithms. Results: The NUTRI-ENDO matrix comprises twelve core nutraceutical categories: Vitamin D3, Vitamin E, Vitamin C, methylfolate, methylcobalamin, magnesium, zinc, selenium, omega-3 polyunsaturated fatty acids (EPA/DHA), N-acetylcysteine (NAC), curcumin, and coenzyme Q10. Each component is stratified by pre-treatment phase (Baseline, Priming, Peri-operative/Pre-ART), with explicit dosing ranges, biochemical targets, and contraindication screening. The NUTRI-ENDO protocol offers a practical, evidence-based framework for clinicians to standardize pre-treatment nutraceutical optimization, potentially improving inflammatory markers, pain scores, and treatment responsiveness in endometriosis patients. Prospective validation studies are warranted.
Full text 2,313 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Objective

To present a standardized, reproducible clinical protocol — NUTRI-ENDO — for pretreatment nutraceutical optimization in endometriosis patients utilizing a structured vitamin-mineral matrix.

Methods

The protocol was developed through systematic review of randomized controlled trials, metaanalyses, and mechanistic studies (2010–2026) concerning nutraceutical modulation of endometriosisassociated inflammation, angiogenesis, apoptosis dysregulation, and estrogen metabolism. A multidisciplinary panel synthesized evidence into a tiered implementation framework with defined dosing, timing, monitoring parameters, and safety algorithms.

Results

The NUTRI-ENDO matrix comprises twelve core nutraceutical categories: Vitamin D3, Vitamin E, Vitamin C, methylfolate, methylcobalamin, magnesium, zinc, selenium, omega-3 polyunsaturated fatty acids (EPA/DHA), N-acetylcysteine (NAC), curcumin, and coenzyme Q10. Each component is stratified by pre-treatment phase (Baseline, Priming, Peri-operative/Pre-ART), with explicit dosing ranges, biochemical targets, and contraindication screening. The NUTRI-ENDO protocol offers a practical, evidence-based framework for clinicians to standardize pre-treatment nutraceutical optimization, potentially improving inflammatory markers, pain scores, and treatment responsiveness in endometriosis patients. Prospective validation studies are warranted. Files NUTRI-ENDO_Protocol_v_2.0.pdf Files (84.5 kB) | Name | Size | Download all | |---|---|---| | md5:598bb027f0102a15e6a7e35d8d6fc11a | 84.5 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-07T06:01:52.021920+00:00
License: CC0 · commercial use OK